• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Long-term cardiovascular complications in COVID-19 survivors according to disease severity

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Oct 29;15(1):37900.
doi: 10.1038/s41598-025-21711-1. Long-term cardiovascular complications in COVID-19 survivors according to disease severity

Anaïs Curtiaud[SUP] 1 2 [/SUP], Antonin Trimaille[SUP] 3 4 [/SUP], François Severac[SUP] 5 [/SUP], Amandine Granier[SUP] 3 [/SUP], Julien Demiselle[SUP] 1 2 [/SUP], Rayane Lakehal[SUP] 1 [/SUP], Julie Helms[SUP] 1 2 [/SUP], Olivier Morel[SUP] 3 4 [/SUP], Ferhat Meziani[SUP] 1 2 [/SUP], Hamid Merdji[SUP] 6 7 [/SUP]



Affiliations
Abstract

Post-sepsis syndrome is a major concern affecting sepsis survivors. COVID-19 increases the risk of long-term complications, but existing data lack detail on patient-specific factors and long-term cardiovascular complications, namely major adverse cardiovascular events (MACE). Our objective was to analyze and compare the MACE occurrence, among COVID-19 survivors, according to the severity of infection. Adults aged ≥ 18 years infected during the first waves of COVID-19 pandemic hospitalized in Strasbourg University Hospital were included. Follow-up began immediately after COVID-19 diagnosis and continued for up to 12 months. Inverse probability of treatment weighting was used to balance baseline patient characteristics between the two groups (i.e. intensive care unit patients and medical ward patients). A total of 332 patients, i.e.132 in intensive care unit (ICU) and 200 in medical ward were included in the final analysis. The ICU population experienced a significantly higher risk of MACE during the first year (HR 16.2 [5.7-45.8] p < 0.001). Smoking status, history of peripheral arterial obstructive disease, and hospitalization in ICU remained independently associated with the occurrence of MACE in multivariable analysis. Severity of COVID-19 appears as an independent risk factor for MACE at one year among intensive care unit patients compared to those hospitalized in medical ward.

Keywords: COVID-19; Cardiovascular outcomes; MACE; Post-intensive care syndrome (PICS); SARS-CoV-2.

 
Back
Top